CA1126274A - Triazolylbenzophenone derivatives and production thereof - Google Patents

Triazolylbenzophenone derivatives and production thereof

Info

Publication number
CA1126274A
CA1126274A CA260,438A CA260438A CA1126274A CA 1126274 A CA1126274 A CA 1126274A CA 260438 A CA260438 A CA 260438A CA 1126274 A CA1126274 A CA 1126274A
Authority
CA
Canada
Prior art keywords
triazol
benzophenone
alkyl
chloro
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA260,438A
Other languages
English (en)
French (fr)
Inventor
Kentaro Hirai
Toshio Fujishita
Teruyuki Ishiba
Hirohiko Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of CA1126274A publication Critical patent/CA1126274A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/92—Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA260,438A 1975-12-30 1976-09-02 Triazolylbenzophenone derivatives and production thereof Expired CA1126274A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof
GB53224/75 1975-12-30

Publications (1)

Publication Number Publication Date
CA1126274A true CA1126274A (en) 1982-06-22

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
CA260,438A Expired CA1126274A (en) 1975-12-30 1976-09-02 Triazolylbenzophenone derivatives and production thereof

Country Status (19)

Country Link
JP (1) JPS5283469A (da)
AR (2) AR218613A1 (da)
AT (1) AT350052B (da)
AU (1) AU498113B2 (da)
BE (1) BE846410A (da)
CA (1) CA1126274A (da)
CH (1) CH623315A5 (da)
DE (1) DE2641164A1 (da)
DK (1) DK393576A (da)
ES (3) ES451896A1 (da)
FR (1) FR2336930A1 (da)
GB (1) GB1531980A (da)
HU (1) HU172539B (da)
IE (1) IE43841B1 (da)
IL (1) IL50664A (da)
NL (1) NL7610799A (da)
NZ (1) NZ181958A (da)
SE (1) SE7609813L (da)
ZA (1) ZA765851B (da)

Also Published As

Publication number Publication date
ES462243A1 (es) 1978-06-01
JPS5283469A (en) 1977-07-12
DE2641164A1 (de) 1977-07-14
HU172539B (hu) 1978-09-28
IE43841L (en) 1977-06-30
IE43841B1 (en) 1981-06-03
NZ181958A (en) 1979-03-28
AU498113B2 (en) 1979-02-08
IL50664A (en) 1983-09-30
NL7610799A (nl) 1977-07-04
AU1749876A (en) 1978-03-16
SE7609813L (sv) 1977-07-01
DK393576A (da) 1977-07-01
IL50664A0 (en) 1976-12-31
ZA765851B (en) 1977-09-28
BE846410A (fr) 1977-01-17
FR2336930A1 (fr) 1977-07-29
AT350052B (de) 1979-05-10
ES462244A1 (es) 1978-06-01
FR2336930B1 (da) 1978-12-22
GB1531980A (en) 1978-11-15
ATA684276A (de) 1978-10-15
AR220519A1 (es) 1980-11-14
CH623315A5 (en) 1981-05-29
ES451896A1 (es) 1978-01-16
AR218613A1 (es) 1980-06-30

Similar Documents

Publication Publication Date Title
TWI454264B (zh) 喹啉基巨環ｃ型肝炎病毒絲胺酸蛋白酶抑制劑
CA2008116C (en) Glycine derivatives
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
NZ244985A (en) Peptide compounds, preparation and pharmaceutical compositions thereof
JP2004527548A (ja) カスパーゼ阻害剤としての複素環ジカルバミド
WO1991015487A1 (en) Novel 4h-3,1-benzoxazin-4-one derivative
EP0831100A1 (en) Novel peptide derivatives
JPS60252495A (ja) スタチンまたはその誘導体を含有するレニン阻害剤
US4386073A (en) Tripeptides acting on the central nervous system and a process for the preparation thereof
TW201536793A (zh) Ｂａｃｅ抑制劑
JPS6210519B2 (da)
US4104371A (en) Psychopharmacologically active peptides and peptide-derivatives, and the use thereof
JPH08505846A (ja) 血小板凝集阻害用化合物
JPS5936611B2 (ja) ペプチドの製造方法
EP0506628A2 (en) Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
US4141901A (en) Process for producing triazolylbenzophenone derivatives
CHATURVEDI et al. Topochemically related hormone structures: Synthesis of Partial Retro‐Inverso Analogs of LH‐RH
US4110322A (en) Peptide derivatives and pharmaceutical compositions containing same
WO1992018488A1 (en) Novel oxazinone derivative
US3856770A (en) Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
HU180925B (en) Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
US3723406A (en) Novel peptides having cholecystokinin activity and intermediates therefor
US4421765A (en) Substituted phenylacetic acid amide compounds
JPH0570495A (ja) 環式ヘキサペプチド化合物
US4421744A (en) Aminoacyl derivatives

Legal Events

Date Code Title Description
MKEX Expiry